We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Colgate-Palmolive
CL
$73.6B
| $13.8M | 0.05% |
186,317
+4,539
| +2% | +$336K |
|
252
Labcorp
LH
$24.7B
| $13.7M | 0.05% |
115,579
+8,513
| +8% | +$1M |
|
253
Cincinnati Financial
CINF
$28.5B
| $13.6M | 0.05% |
180,852
-1,549
| -0.8% | -$117K |
|
254
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $13.6M | 0.05% |
91,535
+1,651
| +2% | +$241K |
|
255
CoStar Group
CSGP
$11.9B
| $13.4M | 0.05% |
620,380
+23,560
| +4% | +$502K |
|
256
Brown-Forman Class B
BF.B
$12.6B
| $13.4M | 0.05% |
440,641
+11,341
| +3% | +$352K |
|
257
Citigroup
C
$223B
| $13.2M | 0.05% |
279,266
+59,151
| +27% | +$2.69M |
|
258
State Street
STT
$50.7B
| $13.1M | 0.05% |
188,554
-2,081
| -1% | -$136K |
|
|
TAST
259
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $12.9M | 0.04% |
+974,867
| New | +$12.6M |
|
|
HOLX
260
DELISTED
Hologic
HOLX
| $12.7M | 0.04% |
326,904
-51,172
| -14% | -$1.93M |
|
261
First Citizens BancShares
FCNCA
$24.3B
| $12.7M | 0.04% |
43,182
-1,200
| -3% | -$327K |
|
262
Vanguard FTSE All-World ex-US ETF
VEU
$65.9B
| $12.7M | 0.04% |
279,289
-29,753
| -10% | -$1.33M |
|
|
KG
263
Kestrel Group
KG
$70.1M
| $12.5M | 0.04% |
49,084
+3,728
| +8% | +$994K |
|
264
Vanguard S&P 500 ETF
VOO
$968B
| $12.2M | 0.04% |
61,453
+7,063
| +13% | +$1.4M |
|
265
Culp Inc
CULP
$45.5M
| $12.2M | 0.04% |
409,516
+1,746
| +0.4% | +$51.6K |
|
266
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
| $12.2M | 0.04% |
447,640
-1,216
| -0.3% | -$33.5K |
|
267
US Bancorp
USB
$98.9B
| $11.8M | 0.04% |
274,756
+32,163
| +13% | +$1.37M |
|
|
XLRN
268
DELISTED
Acceleron Pharma
XLRN
| $11.7M | 0.04% |
323,772
+26,506
| +9% | +$878K |
|
269
iShares US Pharmaceuticals ETF
IHE
$1.48B
| $11.6M | 0.04% |
233,109
-4,365
| -2% | -$221K |
|
270
iShares Russell 1000 Growth ETF
IWF
$120B
| $11.5M | 0.04% |
440,348
+23,368
| +6% | +$608K |
|
271
iShares Residential and Multisector Real Estate ETF
REZ
$904M
| $11.4M | 0.04% |
173,751
-209
| -0.1% | -$14K |
|
|
MIME
272
DELISTED
Mimecast Limited
MIME
| $11.2M | 0.04% |
+587,577
| New | +$8.14M |
|
273
PACCAR
PCAR
$70.2B
| $11.2M | 0.04% |
286,680
-148,817
| -34% | -$5.66M |
|
274
Blackstone
BX
$106B
| $11.2M | 0.04% |
439,715
-33,190
| -7% | -$876K |
|
275
Lindblad Expeditions
LIND
$1.84B
| $11M | 0.04% |
1,219,576
+83,079
| +7% | +$782K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.